C-type natriuretic peptide (CNP) potently and selectively activated the human ANPR-B guanylyl cyclase with a 50- or 500-fold higher affinity than ANP or BNP, respectively.
CNP is identified as a potent and selective ligand for the ANPR-B receptor, suggesting a role in central nervous system fluid homeostasis.
Effect estimate: 50- or 500-fold higher affinity
The natriuretic peptides are hormones that can stimulate natriuretic, diuretic, and vasorelaxant activity in vivo, presumably through the activation of two known cell surface receptor guanylyl cyclases (ANPR-A and ANPR-B). Although atrial natriuretic peptide (ANP) and, to a lesser extent, brain natriuretic peptide (BNP) are efficient activators of the ANPR-A guanylyl cyclase, neither hormone can significantly stimulate ANPR-B. A member of this hormone family, C-type natriuretic peptide (CNP), potently and selectively activated the human ANPR-B guanylyl cyclase. CNP does not increase guanosine 3',5'-monophosphate accumulation in cells expressing human ANPR-A. The affinity of CNP for ANPR-B is 50- or 500-fold higher than ANP or BNP, respectively. This ligand-receptor pair may be involved in the regulation of fluid homeostasis by the central nervous system.
Koller et al. (1991) studied this question. C-Type Natriuretic Peptide (CNP) vs. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) was evaluated on Activation of human ANPR-B guanylyl cyclase (50- or 500-fold higher affinity). C-type natriuretic peptide (CNP) potently and selectively activated the human ANPR-B guanylyl cyclase with a 50- or 500-fold higher affinity than ANP or BNP, respectively.